Results 51 to 60 of about 84,994 (214)

Transcatheter closure of Ventricular Septal defects in Malta : initial experience [PDF]

open access: yes, 2005
Ventricular septal defects (VSD) consist of deficiencies of the wall separating the two ventricles. VSDs are the commonest congenital cardiac defects. Small VSDs rarely require intervention, however, larger defects cause ventricular volume overload with ...
Aquilina, Oscar   +6 more
core  

Update on the Current Landscape of Transcatheter Options for Tricuspid Regurgitation Treatment [PDF]

open access: yes, 2019
Most patients with severe tricuspid regurgitation lack treatment options because of prohibitive surgical risk. New transcatheter treatments under development and investigation might be able to address this unmet clinical need.
Jonathan Curio   +6 more
core   +1 more source

Potential Candidates for Transcatheter Tricuspid Valve Intervention After Transcatheter Aortic Valve Replacement: Predictors and Prognosis. [PDF]

open access: yes, 2021
OBJECTIVES The aims of this study were to document the prevalence of concomitant tricuspid regurgitation (TR) before and after transcatheter aortic valve replacement (TAVR), to quantify potential eligibility for transcatheter tricuspid valve ...
Heg, Dik   +9 more
core   +4 more sources

Transcatheter closure of symptomatic aortopulmonary window in an infant [PDF]

open access: yes, 2008
An aortopulmonary window is a rare congenital cardiac defect. In the majority of symptomatic neonates and infants, primary surgical repair is the treatment of choice.
Brockmeier, Konrad   +4 more
core  

The Next Revolution: Percutaneous Aortic Valve Replacement

open access: yesRambam Maimonides Medical Journal, 2010
Aortic valve replacement (AVR) is a treatment of choice for patients with symptomatic severe aortic stenosis (AS). However, a significant proportion of these patients do not undergo surgical AVR due to high-risk features.
Martin B. Leon, Eugenia Nikolsky
doaj   +1 more source

A Systematic Review of the Design, Method of Implantation and Early Clinical Outcomes of Transcatheter Tricuspid Prostheses

open access: yesReviews in Cardiovascular Medicine, 2023
Background: Intervention for tricuspid regurgitation (TR) tends to happen concurrently with and is addressed during mitral valve surgery. Isolated TR interventions, however, are not unusual and are becoming more common.
Faizus Sazzad   +6 more
doaj   +1 more source

Transcatheter aortic valve implantation with the NVT Allegra transcatheter heart valve system: first-in-human experience with a novel self-expanding transcatheter heart valve.

open access: yes, 2016
AIMS We aimed to demonstrate the feasibility and investigate the safety of a novel, self-expanding trans-catheter heart valve in a selected patient population with severe aortic stenosis. METHODS AND RESULTS Between January and September 2013, a
Glökler, Steffen   +6 more
core   +1 more source

Predicting mortality after transcatheter aortic valve replacement external validation of the Transcatheter Valve Therapy registry model [PDF]

open access: yes, 2017
BACKGROUND: The Transcatheter Valve Therapy (TVT) registry model was recently developed to predict the risk of in-hospital mortality in patients undergoing transcatheter aortic valve replacement.
Oliver Muller   +34 more
core   +4 more sources

Assessment of D-Shaped Annulus of Mitral Valve in Patients with Severe MR Using Semi-Automated 4-Dimensional Analysis: Implications for Transcatheter Interventions

open access: yesJournal of Cardiovascular Development and Disease, 2020
The development of transcatheter mitral valve replacement therapies requires accurate post-processing analysis tools to provide D-shaped mitral annulus dimensions from 3-dimensional (3D) data.
N. Mai Vo   +4 more
doaj   +1 more source

Transcatheter Mitral Valve Replacement in the Transcatheter Aortic Valve Replacement Era

open access: yesJournal of the American Heart Association, 2019
After the success and worldwide adoption of transcatheter aortic valve replacement (TAVR), the percutaneous replacement of a diseased mitral valve (MV) rapidly became a target for investigators and industry. The rejuvenated enthusiasm of industry in this field is also corroborated by the fact that, in 2015, ≈2.5 billion dollars were invested in MV ...
Luca Testa   +5 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy